METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat digestive tumors
Disease control OngoingThis study is testing whether the drug abemaciclib can help control advanced digestive system neuroendocrine tumors that have spread and stopped responding to standard treatments. The drug works by blocking enzymes that tumor cells need to grow. About 20 patients with these speci…
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test Two-Pronged attack on rare digestive cancers
Disease control OngoingThis early-stage study is testing a new combination of two drugs for people with advanced neuroendocrine tumors that have spread. The goal is to find the safest and most effective dose by giving patients an oral drug (triapine) alongside a targeted radiation therapy (lutetium Lu …
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for slowing advanced neuroendocrine tumors in major trial
Disease control OngoingThis study is testing if a drug called cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo (inactive pill). It is for about 298 patients whose cancer has continued to grow despite receiving at least one prior standard treatment. The main goal …
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC